What is Niraparib and Abiraterone: Uses, Dosage, Side Effects and More

Niraparib and abiraterone are two distinct cancer medications that work in different ways to fight specific types of cancer. Niraparib helps repair damaged cancer cells while abiraterone blocks hormones that fuel certain cancers. Both medications represent important advances in targeted cancer treatment, offering hope and improved outcomes for patients facing these challenging diagnoses.

What is Niraparib?

Niraparib is a targeted cancer medication that belongs to a class of drugs called PARP inhibitors. It works by blocking an enzyme that cancer cells need to repair their damaged DNA, ultimately causing the cancer cells to die.

This medication is specifically designed for certain types of ovarian, fallopian tube, and primary peritoneal cancers. Your doctor prescribes niraparib when your cancer has specific genetic characteristics that make it particularly vulnerable to this type of treatment.

What is Abiraterone?

Abiraterone is a hormone therapy medication used to treat advanced prostate cancer. It works by blocking the production of testosterone and other male hormones that prostate cancer cells need to grow and spread.

This medication is particularly effective for prostate cancers that have spread to other parts of the body or have stopped responding to other hormone treatments. Abiraterone helps slow down cancer progression and can improve quality of life for many patients.

What is Niraparib Used For?

Niraparib is primarily used to treat ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. Your doctor may prescribe it as maintenance therapy after you've completed chemotherapy and your cancer has responded well to treatment.

The medication is especially effective for cancers with BRCA gene mutations or other DNA repair defects. These genetic changes make cancer cells more vulnerable to PARP inhibitors like niraparib, giving the treatment a better chance of success.

What is Abiraterone Used For?

Abiraterone treats metastatic castration-resistant prostate cancer, which means prostate cancer that has spread and no longer responds to standard hormone therapy. It's often used when other treatments have stopped working effectively.

Your doctor might prescribe abiraterone in combination with prednisone to help manage side effects. This combination therapy has shown significant benefits in extending survival and improving symptoms for many patients with advanced prostate cancer.

How Does Niraparib Work?

Niraparib works by targeting a specific weakness in cancer cells. It blocks PARP enzymes, which are like molecular repair tools that fix damaged DNA inside cells.

When healthy cells suffer DNA damage, they can repair themselves using multiple pathways. Cancer cells with BRCA mutations or similar genetic defects have fewer repair options available. By blocking PARP with niraparib, these cancer cells can't fix their DNA damage and eventually die.

This targeted approach means niraparib can be particularly effective while causing less harm to healthy cells that have intact DNA repair systems.

How Does Abiraterone Work?

Abiraterone works by blocking an enzyme called CYP17A1, which is essential for producing testosterone and other androgens. These male hormones act like fuel for prostate cancer cells, helping them grow and multiply.

The medication stops hormone production not just in the testicles, but also in the adrenal glands and even within the cancer cells themselves. This comprehensive approach helps ensure that prostate cancer cells are starved of the hormones they need to survive.

Since abiraterone also affects cortisol production, it's always given with prednisone to replace this important hormone and prevent side effects.

How Should I Take Niraparib?

Take niraparib exactly as your doctor prescribes, usually once daily at the same time each day. You should take it on an empty stomach, at least one hour before eating or two hours after eating.

Swallow the capsules whole with water and don't crush, chew, or open them. If you have trouble swallowing, talk to your healthcare team about alternatives rather than breaking the capsules.

Your doctor will likely start you on a specific dose and may adjust it based on how you respond and what side effects you experience. Regular blood tests will help monitor your body's response to the medication.

How Should I Take Abiraterone?

Take abiraterone on an empty stomach, at least one hour before eating or two hours after eating. Food can significantly increase how much medication your body absorbs, which could lead to dangerous side effects.

Always take abiraterone with prednisone as prescribed by your doctor. The prednisone helps prevent serious side effects related to hormone changes. Take both medications at the same time each day to maintain consistent levels in your system.

Swallow the tablets whole with water and avoid crushing or chewing them. If you have difficulty swallowing, discuss alternatives with your healthcare provider.

How Long Should I Take Niraparib?

The duration of niraparib treatment varies significantly from person to person. Some patients take it for months, while others may continue for years, depending on how well the cancer responds and how you tolerate the medication.

Your doctor will monitor you regularly with scans and blood tests to assess whether the treatment is working. You'll continue taking niraparib as long as it's helping control your cancer and the benefits outweigh any side effects you're experiencing.

Never stop taking niraparib without discussing it with your oncologist first. Even if you feel well, the medication may still be working to keep your cancer under control.

How Long Should I Take Abiraterone?

Most patients take abiraterone for as long as it continues to control their cancer effectively. This could be months or even years, depending on how your individual cancer responds to treatment.

Your doctor will monitor your progress through regular blood tests, scans, and physical examinations. These check-ups help determine whether the medication is still working and whether any adjustments are needed.

Treatment typically continues until your cancer progresses despite the medication or until side effects become too difficult to manage. Your healthcare team will work with you to determine the best course of action.

What Are the Side Effects of Niraparib?

Niraparib can cause various side effects, though not everyone experiences all of them. The most common side effects tend to be manageable with proper medical support and monitoring.

Here are the more common side effects you might experience:

• Fatigue and weakness that may affect daily activities
• Nausea and vomiting, especially during the first few weeks
• Low blood cell counts, which can increase infection risk
• Decreased appetite and weight loss
• Constipation or diarrhea
• Headaches and dizziness
• Difficulty sleeping or insomnia

Some patients may experience more serious but less common side effects that require immediate medical attention. These include severe fatigue that doesn't improve, signs of infection like fever or persistent cough, unusual bleeding or bruising, and difficulty breathing.

Rarely, niraparib can cause a condition called myelodysplastic syndrome or acute myeloid leukemia, which are serious blood disorders. Your doctor will monitor your blood counts regularly to watch for early signs of these conditions.

What Are the Side Effects of Abiraterone?

Abiraterone can cause side effects related to its hormone-blocking action. Most side effects are manageable when you take the medication with prednisone as prescribed.

Common side effects you might experience include:

• Fatigue and weakness that may improve over time
• Joint pain and muscle aches
• Swelling in legs, feet, or hands
• Hot flashes and night sweats
• Diarrhea or constipation
• Headaches and dizziness
• Changes in blood pressure

More serious side effects can include liver problems, which is why your doctor will monitor liver function with regular blood tests. Heart problems and severe drops in potassium levels are also possible but less common.

Some patients experience mood changes, including depression or anxiety. These emotional effects are valid and treatable, so don't hesitate to discuss them with your healthcare team.

Who Should Not Take Niraparib?

Niraparib isn't suitable for everyone. Your doctor will carefully evaluate whether this medication is safe for you based on your medical history and current health status.

You should not take niraparib if you're pregnant or breastfeeding, as it can harm a developing baby. Women of childbearing age need to use effective contraception during treatment and for six months after stopping the medication.

People with severe kidney or liver problems may not be able to take niraparib safely. Your doctor will check your organ function before starting treatment and monitor it regularly throughout therapy.

If you've had previous severe allergic reactions to niraparib or similar medications, this treatment may not be appropriate for you. Always inform your doctor about any medication allergies you've experienced.

Who Should Not Take Abiraterone?

Abiraterone isn't appropriate for all patients with prostate cancer. Your doctor will assess your overall health and medical history to determine if this treatment is safe for you.

Men with severe liver disease cannot safely take abiraterone, as the medication can worsen liver problems. Your doctor will test your liver function before starting treatment and continue monitoring it throughout therapy.

If you have severe heart problems or uncontrolled high blood pressure, abiraterone may not be suitable. The medication can affect heart function and blood pressure, so these conditions need to be well-managed before starting treatment.

People with severe adrenal gland problems may need special monitoring or may not be candidates for abiraterone. Your healthcare team will evaluate your hormone levels and adrenal function before beginning therapy.

Niraparib Brand Names

Niraparib is available under the brand name Zejula in most countries. This is the most commonly prescribed form of the medication and the one most insurance plans recognize.

Some regions may have different brand names or generic versions available. Always check with your pharmacist to ensure you're receiving the correct medication, and don't switch between different forms without consulting your doctor first.

Abiraterone Brand Names

Abiraterone is most commonly available under the brand name Zytiga. This is the original formulation that most doctors prescribe and that insurance companies typically cover.

Generic versions of abiraterone are now available in many countries, which can help reduce costs. However, always confirm with your doctor before switching between brand name and generic versions to ensure consistent treatment.

Niraparib Alternatives

If niraparib isn't suitable for you, other PARP inhibitors might be options. Olaparib and rucaparib work similarly to niraparib and may be appropriate depending on your specific cancer type and genetic profile.

For ovarian cancer maintenance therapy, your doctor might also consider bevacizumab or returning to chemotherapy if PARP inhibitors aren't working. The choice depends on your cancer's characteristics and your previous treatment history.

Clinical trials may offer access to newer medications that aren't yet widely available. Your oncologist can help you explore whether any research studies might be appropriate for your situation.

Abiraterone Alternatives

Several other medications can treat advanced prostate cancer if abiraterone isn't suitable. Enzalutamide works differently by blocking androgen receptors rather than stopping hormone production.

Newer medications like apalutamide and darolutamide may be options for certain stages of prostate cancer. Chemotherapy drugs like docetaxel or cabazitaxel might also be considered depending on your specific situation.

Your oncologist will consider factors like your cancer's progression, previous treatments, and overall health when recommending alternatives. Each option has different benefits and side effects to weigh.

Is Niraparib Better Than Olaparib?

Both niraparib and olaparib are effective PARP inhibitors, but they're not necessarily better or worse than each other. The choice between them depends on your specific cancer type, genetic profile, and individual circumstances.

Niraparib has shown particular effectiveness in ovarian cancer maintenance therapy, regardless of BRCA status. Olaparib has been studied in both ovarian and breast cancers and may be preferred for patients with confirmed BRCA mutations.

Side effect profiles differ slightly between the two medications. Your doctor will consider which side effects you're most likely to tolerate based on your health history and lifestyle. The decision should always be made together with your oncologist based on your unique situation.

Is Abiraterone Better Than Enzalutamide?

Abiraterone and enzalutamide are both effective treatments for advanced prostate cancer, but they work through different mechanisms. Neither is universally better than the other, and the choice depends on your individual circumstances.

Abiraterone blocks hormone production, while enzalutamide blocks how cancer cells respond to hormones. Some patients may respond better to one approach than the other based on their cancer's specific characteristics.

Side effect profiles differ between the medications. Abiraterone requires prednisone and may cause more fluid retention, while enzalutamide can cause fatigue and potential seizures in rare cases. Your doctor will help you weigh these factors when choosing treatment.